Skip to main content
. 2023 Jan 1;19(1):258–280. doi: 10.7150/ijbs.66839

Figure 4.

Figure 4

Epigenetic modification and genetic alteration of 3 key genes. A. The DNA alteration of 3 key genes. B. Tumor mutation burden of 3 key genes. C. The estimated IC50 values of cisplatin, docetaxel, erlotinib, gefitinib and paclitaxel for 3 key genes. D. The DNA promoter methylation levels of 3 key genes based on the TCGA database.